Canada Pension Plan Investment Board purchased a new stake in Avanos Medical, Inc. (NYSE:AVNS – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 22,900 shares of the company’s stock, valued at approximately $570,000.
A number of other hedge funds have also recently made changes to their positions in the company. AQR Capital Management LLC increased its holdings in shares of Avanos Medical by 46.4% in the first quarter. AQR Capital Management LLC now owns 192,864 shares of the company’s stock worth $2,700,000 after purchasing an additional 61,095 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Avanos Medical by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,955 shares of the company’s stock worth $386,000 after buying an additional 1,121 shares in the last quarter. Millennium Management LLC grew its position in Avanos Medical by 508.3% during the first quarter. Millennium Management LLC now owns 547,740 shares of the company’s stock worth $7,849,000 after buying an additional 457,703 shares in the last quarter. Empowered Funds LLC increased its stake in Avanos Medical by 5.4% in the 1st quarter. Empowered Funds LLC now owns 162,182 shares of the company’s stock worth $2,324,000 after acquiring an additional 8,348 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Avanos Medical by 17.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 140,810 shares of the company’s stock worth $2,018,000 after acquiring an additional 20,541 shares during the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.
Avanos Medical Stock Performance
NYSE AVNS opened at $24.99 on Wednesday. Avanos Medical, Inc. has a 52-week low of $9.30 and a 52-week high of $25.49. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.40 and a current ratio of 2.48. The company has a market capitalization of $1.17 billion, a P/E ratio of -15.52 and a beta of 1.57. The company has a fifty day moving average of $24.97 and a 200-day moving average of $21.59.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on AVNS
Avanos Medical Company Profile
Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.
In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.
Featured Articles
- Five stocks we like better than Avanos Medical
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
